Goldman Sachs Group Inc Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,160,172 shares of PPH stock, worth $102 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,160,172
Previous 1,160,172 -0.0%
Holding current value
$102 Million
Previous $106 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$85.24 - $94.86 $96.5 Million - $107 Million
-1,131,549 Reduced 49.38%
1,160,172 $106 Million
Q4 2024

Feb 11, 2025
BUY
$86.03 - $94.92 $16.8 Million - $18.5 Million
194,720 Added 9.29%
2,291,721 $198 Million
Q3 2024

Nov 14, 2024
BUY
$90.59 - $99.43 $58.9 Million - $64.6 Million
650,000 Added 44.92%
2,097,001 $199 Million
Q2 2024

Aug 13, 2024
BUY
$84.87 - $93.23 $8.49 Million - $9.32 Million
100,000 Added 7.42%
1,447,001 $132 Million
Q1 2024

May 15, 2024
SELL
$82.63 - $90.89 $4.13 Million - $4.54 Million
-49,999 Reduced 3.58%
1,347,001 $122 Million
Q4 2023

Feb 13, 2024
SELL
$74.32 - $81.37 $18.7 Million - $20.4 Million
-250,971 Reduced 15.23%
1,397,000 $114 Million
Q3 2023

May 14, 2024
BUY
$76.26 - $83.18 $19.1 Million - $20.9 Million
250,971 Added 17.96%
1,647,971 $132 Million
Q3 2023

Nov 14, 2023
BUY
$76.26 - $83.18 $40.6 Million - $44.3 Million
532,285 Added 47.71%
1,647,971 $132 Million
Q2 2023

May 14, 2024
SELL
$75.02 - $80.55 $36.3 Million - $39 Million
-484,213 Reduced 30.27%
1,115,686 $87.9 Million
Q2 2023

Aug 14, 2023
SELL
$75.02 - $80.55 $36.3 Million - $39 Million
-484,213 Reduced 30.27%
1,115,686 $87.9 Million
Q1 2023

May 14, 2024
SELL
$73.68 - $79.63 $18.6 Million - $20.1 Million
-252,488 Reduced 13.63%
1,599,899 $124 Million
Q1 2023

May 11, 2023
SELL
$73.68 - $79.63 $18.6 Million - $20.1 Million
-252,488 Reduced 13.63%
1,599,899 $124 Million
Q4 2022

May 14, 2024
SELL
$67.31 - $79.26 $16.8 Million - $19.8 Million
-249,870 Reduced 11.89%
1,852,387 $144 Million
Q4 2022

Feb 13, 2023
SELL
$67.31 - $79.26 $16.8 Million - $19.8 Million
-249,870 Reduced 11.89%
1,852,387 $144 Million
Q3 2022

May 14, 2024
BUY
$66.73 - $77.98 $116 Million - $136 Million
1,742,570 Added 484.47%
2,102,257 $141 Million
Q3 2022

Nov 10, 2022
BUY
$66.73 - $77.98 $116 Million - $136 Million
1,742,570 Added 484.47%
2,102,257 $0
Q2 2022

May 14, 2024
SELL
$72.65 - $83.96 $75.4 Million - $87.1 Million
-1,037,313 Reduced 74.25%
359,687 $27.6 Million
Q2 2022

Aug 15, 2022
BUY
$72.65 - $83.96 $15.4 Million - $17.8 Million
212,560 Added 144.47%
359,687 $27.6 Million
Q1 2022

May 16, 2022
SELL
$73.73 - $80.41 $15,409 - $16,805
-209 Reduced 0.14%
147,127 $11.7 Million
Q4 2021

Feb 14, 2022
BUY
$71.36 - $77.51 $14,914 - $16,199
209 Added 0.14%
147,336 $11.3 Million
Q3 2021

Nov 10, 2021
BUY
$72.19 - $77.22 $10.6 Million - $11.4 Million
147,127 New
147,127 $10.7 Million

Others Institutions Holding PPH

# of Institutions
146
Shares Held
5.84M
Call Options Held
18.3K
Put Options Held
611K
View Full List

About VANECK ETF TR VANECK PHARMACEU

PPH Quotes by TradingView
  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email